Literature DB >> 15549774

Development of CD1d-restricted NKT cells in the mouse thymus.

Tao Dao1, Donglin Guo, Alexander Ploss, Amy Stolzer, Carolyn Saylor, Tamar E Boursalian, Jin Seon Im, Derek B Sant'Angelo.   

Abstract

Using genetic and phenotypic analyses, we have analyzed the developmental pathway of mouse CD1d-restricted invariant NKT cells. We provide strong evidence that similar to conventional T cells, positive selection of NKT cells occurs during a CD4(+)CD8(+) stage. Later stages of NKT cell development involved the down-regulation of both TCR and CD4 levels and therefore diverge from conventional T cell development pathways. A unique and complete dependency for development on Fyn, a Src family kinase member, also distinguishes the NKT cell and conventional T cell populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15549774     DOI: 10.1002/eji.200425546

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

1.  T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells.

Authors:  Jennifer L Matsuda; Qianjun Zhang; Rachel Ndonye; Stewart K Richardson; Amy R Howell; Laurent Gapin
Journal:  Blood       Date:  2005-12-15       Impact factor: 22.113

2.  TRIM28 mediates chromatin modifications at the TCRα enhancer and regulates the development of T and natural killer T cells.

Authors:  Xiao-Fei Zhou; Jiayi Yu; Mikyoung Chang; Minying Zhang; Dapeng Zhou; Florence Cammas; Shao-Cong Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

Review 3.  Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions.

Authors:  Patrick J Brennan; Manfred Brigl; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2013-01-21       Impact factor: 53.106

4.  Transcriptional control of invariant NKT cell development.

Authors:  Rupali Das; Derek B Sant'Angelo; Kim E Nichols
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

5.  TCRα-TCRβ pairing controls recognition of CD1d and directs the development of adipose NKT cells.

Authors:  Joshua A Vieth; Joy Das; Fanomezana M Ranaivoson; Davide Comoletti; Lisa K Denzin; Derek B Sant'Angelo
Journal:  Nat Immunol       Date:  2016-11-21       Impact factor: 25.606

6.  The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions.

Authors:  Damian Kovalovsky; Olisambu U Uche; Sonia Eladad; Robin M Hobbs; Woelsung Yi; Eric Alonzo; Kevin Chua; Maggie Eidson; Hye-Jung Kim; Jin S Im; Pier Paolo Pandolfi; Derek B Sant'Angelo
Journal:  Nat Immunol       Date:  2008-07-27       Impact factor: 25.606

7.  The SLAM-associated protein signaling pathway is required for development of CD4+ T cells selected by homotypic thymocyte interaction.

Authors:  Wei Li; M Hanief Sofi; Svend Rietdijk; Ninghai Wang; Cox Terhorst; Cheong-Hee Chang
Journal:  Immunity       Date:  2007-11       Impact factor: 31.745

8.  Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis.

Authors:  Chris M Olson; Tonya C Bates; Hooman Izadi; Justin D Radolf; Sally A Huber; Jonathan E Boyson; Juan Anguita
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

9.  NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi.

Authors:  Emmanuel Tupin; Mohammed Rafii-El-Idrissi Benhnia; Yuki Kinjo; Rebeca Patsey; Christopher J Lena; Matthew C Haller; Melissa J Caimano; Masakazu Imamura; Chi-Huey Wong; Shane Crotty; Justin D Radolf; Timothy J Sellati; Mitchell Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-05       Impact factor: 11.205

10.  Beta-glycoglycosphingolipid-induced alterations of the STAT signaling pathways are dependent on CD1d and the lipid raft protein flotillin-2.

Authors:  Gadi Lalazar; Ami Ben Ya'acov; Dan M Livovsky; Madi El Haj; Orit Pappo; Sarah Preston; Lidya Zolotarov; Yaron Ilan
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.